Control Net Income From Continuing Ops from 2010 to 2026

CBL Stock   0.07  0  1.47%   
Control Bionics Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to about -5.6 M in 2026. From the period from 2010 to 2026, Control Bionics Net Loss quarterly data regression had mean square error of 456.9 B and mean deviation of  1,002,248. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-5.3 M
Current Value
-5.6 M
Quarterly Volatility
1.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Control Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Control Bionics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 93.2 K or Selling General Administrative of 1.3 M, as well as many indicators such as . Control financial statements analysis is a perfect complement when working with Control Bionics Valuation or Volatility modules.
  
This module can also supplement various Control Bionics Technical models . Check out the analysis of Control Bionics Correlation against competitors.

Latest Control Bionics' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Control Bionics over the last few years. It is Control Bionics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Control Bionics' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Control Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(4,325,290)
Coefficient Of Variation(25.26)
Mean Deviation1,002,248
Median(3,550,826)
Standard Deviation1,092,403
Sample Variance1.2T
Range2.6M
R-Value(0.80)
Mean Square Error456.9B
R-Squared0.64
Significance0.0001
Slope(173,205)
Total Sum of Squares19.1T

Control Net Income From Continuing Ops History

2026-5.6 M
2025-5.3 M
2023-5.9 M
2022-5.6 M
2021-6.1 M

About Control Bionics Financial Statements

Control Bionics shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Control Bionics investors may analyze each financial statement separately, they are all interrelated. The changes in Control Bionics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Control Bionics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-5.3 M-5.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Control Stock Analysis

When running Control Bionics' price analysis, check to measure Control Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Control Bionics is operating at the current time. Most of Control Bionics' value examination focuses on studying past and present price action to predict the probability of Control Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Control Bionics' price. Additionally, you may evaluate how the addition of Control Bionics to your portfolios can decrease your overall portfolio volatility.